Brain cytoprotection of ischemic stroke in the era of effective reperfusion  

缺血性卒中血流再通时代的脑细胞保护新策略

作　　者：Di Wu Ming Li Marc Fisher Xunming Ji 吴迪;李明;Marc Fisher;吉训明(Department of Neurology and China-America Institute of Neuroscience,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Bejing Institute of Brain Disorders,Capital Medical University,Beijing 100053,China;Departmentof Neurology,Beth Israel Deaconess Medical Center,Harvard Medical School,Boston 02215,USA)

机构地区：[1]Department of Neurology and China-America Institute of Neuroscience,Xuanwu Hospital,Capital Medical University,Beijing 100053,China [2]Bejing Institute of Brain Disorders,Capital Medical University,Beijing 100053,China [3]Departmentof Neurology,Beth Israel Deaconess Medical Center,Harvard Medical School,Boston 02215,USA

出　　处：《Science Bulletin》2022年第23期2372-2375,共4页科学通报（英文版）

基　　金：supported by the National Natural Science Foundation of China (82027802, 82071466, and 82102220)。

摘　　要：Acute ischemic stroke (AIS) treatment has been advanced by the development of recanalization therapies, especially endovascular thrombectomy. Thrombectomy has led to a better prognosis at 90 d not only in stroke patients because of large-vessel occlusion in the proximal anterior cerebral circulation, but also in those due to basilar-artery occlusion [1]. Thus, the number of eligible patients for revascularization will continue to increase.

关 键 词：缺血性卒中 OCCLUSION ACUTE 

分 类 号：R743.3[医药卫生—神经病学与精神病学]